Richter-Helm´s Biomanufacturing Facility Expansion progress: inauguration of the new office building

Richter-Helm BioLogics has reached a further and important construction milestone during the expansion of its production site in Bovenau. We officially and ceremoniously inaugurated the new office building on May 31, 2023 together with the mayor of Bovenau, Mr. Ambrock, two years after the groundbreaking ceremony.

“The new office building offers our employees a modern open-space workplace including an in-house canteen. Next week our employees will be able to move in and start their work.” said Dr. Pohlmeyer, Managing Director at Richter-Helm.

(source:  Richter-Helm intern, 2023)

With an invest of 95 million € Richter-Helm is going to triple the current production capacity by the installment of two additional highly flexible and fully equipped production trains with interchangeable product flows offering further capacities for late stage and commercial products. Bioreactor capacities of 300 litres and 1,500 litres will be added.

By mid of next year we will be able to start GMP-compliant production in the new site offering space for new clients and their pDNA and protein-based projects.

This might interest you

Delivering flexible and transparent manufacturing processes

Developing and manufacturing microbial-derived biopharmaceutical products require deep expertise and reliable solutions that can guide a project to success while meeting evolving industry standards. To this end, pharmaceutical companies need expert partners capable of bringing promising cures to the market on time, regardless of scale.

read more

Leveraging Experience To Support Biologics Manufacturingfrom Gene to Product

In recent years, customer requirements for contract development and manufacturing organization (CDMO) services have changed. CDMOs have developed into partners, consultants, and providers of specific services, all preferably coming from a single source. Richter-Helm is one driver of a transparent, flexible, guided, and solution-oriented way of partnership, offering its clients a full-service approach along the entire journey from gene to finished product.

read more